IDEA Pharma × Kyverna | Strategic Pitch Microsite IDEA IDEA Pharma × Kyverna OpportunityIDEA MethodPathsNarrativesEngagement Private strategic pitch concept For […]
The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.
Welcome to a special edition of IDEA Collider’s “Deep Medicine” series. In this episode, host Alex Gray sits down with
The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior
How I Learned to Love My ATU
Our Best Practices for Tracking Research. Tracking research is a foundational part of any market research plan. Studies under the
Accurate Product Forecasting
An accurate prediction of future market share can help optimize strategy beyond sales and marketing, impacting decisions as far-reaching as
Choose Your Own Adventure
A unique Market Research approach to inform rare disease education. The Challenge. One of the common challenges orphan drug makers
Using Archetypes to Understand Prescribing Decisions
Healthcare marketing now recognizes that prescribing decisions—like all decisions—are never purely rational. But the search to identify heuristics and other
How and Why to Execute Rare Disease Patient Journey Market Research
We all appreciate the importance of empathy in patient interactions. However, this understanding is even more important in the world
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray is joined by IDEA Pharma colleagues David Radwaner and
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is